Back to search
Thymidine Kinase 2 Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thymidine Kinase 2 Deficiency trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Thymidine Kinase 2 Deficiency trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This Expanded Access Record for doxecitine and doxribtimine includes the following managed access programs and status: * TK0113: Available * TK0115: No longer…
This is a Phase 2 prospective open-label treatment study of the safety and efficacy of doxecitine and doxribtimine in study participants with thymidine kinase 2…